Wenjun Wang

3.0k total citations · 2 hit papers
70 papers, 2.0k citations indexed

About

Wenjun Wang is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Wenjun Wang has authored 70 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 26 papers in Oncology and 14 papers in Organic Chemistry. Recurrent topics in Wenjun Wang's work include Carbohydrate Chemistry and Synthesis (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Glycosylation and Glycoproteins Research (5 papers). Wenjun Wang is often cited by papers focused on Carbohydrate Chemistry and Synthesis (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Glycosylation and Glycoproteins Research (5 papers). Wenjun Wang collaborates with scholars based in China, United States and Macao. Wenjun Wang's co-authors include Si-Pei Wu, Yongsheng Shi, Zebo Jiang, Ya‐Jia Xie, Kai‐Tai Yao, Qibiao Wu, Elaine Lai‐Han Leung, Jumin Huang, Xing‐Xing Fan and Jiabin Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Wenjun Wang

66 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biodegradable hydrogel with thermo-response and hemostatic effect for photothermal enhanced anti-infective therapy

2021 185 citations Yanling Hu, Dongliang Yang et al. profile →
Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer

2021 177 citations Zebo Jiang, Wenjun Wang et al. Cancer Letters profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wenjun Wang China	24	828	538	348	298	224	70	2.0k
Jawed A. Siddiqui United States	31	1.5k 1.8×	673 1.3×	300 0.9×	353 1.2×	268 1.2×	79	2.8k
Mariusz Kaczmarek Poland	23	730 0.9×	401 0.7×	414 1.2×	230 0.8×	251 1.1×	119	2.1k
Xiaochun Peng China	23	807 1.0×	490 0.9×	321 0.9×	226 0.8×	181 0.8×	74	1.8k
Haigang Li China	26	562 0.7×	438 0.8×	195 0.6×	187 0.6×	231 1.0×	101	1.8k
Meng Cao China	21	947 1.1×	349 0.6×	511 1.5×	395 1.3×	164 0.7×	103	2.0k
Jie Ma China	28	1.5k 1.8×	420 0.8×	327 0.9×	490 1.6×	266 1.2×	210	2.9k
Ana Cristina Gonçalves Portugal	27	1.2k 1.5×	588 1.1×	177 0.5×	568 1.9×	287 1.3×	132	2.7k
Qiwei Jiang China	27	1.1k 1.3×	421 0.8×	166 0.5×	389 1.3×	259 1.2×	61	1.9k
Liqun Chen China	28	1.4k 1.7×	488 0.9×	309 0.9×	544 1.8×	187 0.8×	69	2.7k
Tianhui Hu China	31	1.4k 1.7×	364 0.7×	229 0.7×	439 1.5×	111 0.5×	111	2.7k

Countries citing papers authored by Wenjun Wang

Since Specialization

Citations

This map shows the geographic impact of Wenjun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjun Wang more than expected).

Fields of papers citing papers by Wenjun Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenjun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjun Wang. The network helps show where Wenjun Wang may publish in the future.

Co-authorship network of co-authors of Wenjun Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Wenjun Wang. A scholar is included among the top collaborators of Wenjun Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenjun Wang. Wenjun Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jiang, Zebo, Qiang He, Liping Kang, et al.. (2025). Rutecarpine Suppresses Non‐Small Cell Lung Cancer Progression Through Activating the STING Pathway and Elevating CD8+ T Cells. Chemical Biology & Drug Design. 105(2). e70070–e70070.

Wang, Wenjun, Shuping Zhou, Yun Liang, Chuanwei Ma, & Xia Wan. (2024). Psychological Effects of Noise Exposure on Personnel in Central Sterile Supply Department in China. Psychology Research and Behavior Management. Volume 17. 4221–4235.

Wang, Wenjun, Zhouhua Li, Juan Wu, et al.. (2023). Delta-like ligand 3 in small cell lung cancer: Potential mechanism and treatment progress. Critical Reviews in Oncology/Hematology. 191. 104136–104136. 4 indexed citations

Xu, Yanchao, Xinyi Lv, Hui Li, et al.. (2023). Environment-triggered nanoagent with programmed gas release performance for accelerating diabetic infected wound healing. Chemical Engineering Journal. 479. 147645–147645. 31 indexed citations

Wang, Jian, Wenjun Wang, Lee‐Fong Yau, et al.. (2023). CERS4 predicts positive anti-PD-1 response and promotes immunomodulation through Rhob-mediated suppression of CD8+Tim3+ exhausted T cells in non-small cell lung cancer. Pharmacological Research. 194. 106850–106850. 13 indexed citations

Wang, Jingjing, et al.. (2022). Associations of Epstein-Barr Virus Infection with Attention Deficit Hyperactivity Disorder, Learning Disability, and Special Education in US Children. SHILAP Revista de lepidopterología. 3 indexed citations

Zhang, Ling, et al.. (2022). Cyclophilin D: Guardian or Executioner for Tumor Cells?. Frontiers in Oncology. 12. 939588–939588. 10 indexed citations

Jiang, Zebo, Wenjun Wang, Cong Xu, et al.. (2021). Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer. Cancer Letters. 515. 36–48. 177 indexed citations breakdown →

Jiang, Zebo, Cong Xu, Wenjun Wang, et al.. (2021). Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8+ T cells. Pharmacological Research. 169. 105656–105656. 33 indexed citations

10.

Yang, Jing, Si-Pei Wu, Wenjun Wang, et al.. (2020). A novel miR-200c/c-myc negative regulatory feedback loop is essential to the EMT process, CSC biology and drug sensitivity in nasopharyngeal cancer. Experimental Cell Research. 391(2). 111817–111817. 21 indexed citations

11.

Jiang, Zebo, Jumin Huang, Ya‐Jia Xie, et al.. (2020). Evodiamine suppresses non-small cell lung cancer by elevating CD8+ T cells and downregulating the MUC1-C/PD-L1 axis. Journal of Experimental & Clinical Cancer Research. 39(1). 249–249. 93 indexed citations

12.

Wang, Wenjun, Huanling Lai, Yuwei Wang, et al.. (2020). Dolutegravir derivative inhibits proliferation and induces apoptosis of non-small cell lung cancer cells via calcium signaling pathway. Pharmacological Research. 161. 105129–105129. 30 indexed citations

13.

Wu, Si-Pei, Ri-Qiang Liao, Hai‐Yan Tu, et al.. (2017). Stromal PD-L1–Positive Regulatory T cells and PD-1–Positive CD8-Positive T cells Define the Response of Different Subsets of Non–Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy. Journal of Thoracic Oncology. 13(4). 521–532. 120 indexed citations

14.

Wang, Xintao, Pijun Wang, Wenjun Wang, John W. Murray, & Allan W. Wolkoff. (2015). The Na ⁺ ‐Taurocholate Cotransporting Polypeptide Traffics with the Epidermal Growth Factor Receptor. Traffic. 17(3). 230–244. 8 indexed citations

15.

Wang, Cheng, Wenjun Wang, Yiguo Yan, et al.. (2015). MicroRNAs: New players in intervertebral disc degeneration. Clinica Chimica Acta. 450. 333–341. 72 indexed citations

16.

Chen, Weiguo, Si-Pei Wu, Gong Zhang, Wenjun Wang, & Yongsheng Shi. (2013). Effect of AKT inhibition on epithelial-mesenchymal transition and ZEB1-potentiated radiotherapy in nasopharyngeal carcinoma. Oncology Letters. 6(5). 1234–1240. 23 indexed citations

17.

Wang, Wenjun, Xiashi Zhu, & Chao‐Guo Yan. (2013). Determination of safranine T in food samples by CTAB sensitised fluorescence quenching method of the derivatives of calix[4]arene. Food Chemistry. 141(3). 2207–2212. 12 indexed citations

18.

Wang, Wenjun, Si-Pei Wu, Jiabin Liu, et al.. (2012). MYC Regulation of CHK1 and CHK2 Promotes Radioresistance in a Stem Cell-like Population of Nasopharyngeal Carcinoma Cells. Cancer Research. 73(3). 1219–1231. 177 indexed citations

19.

Wang, Wenjun, Jinxi Chen, Li‐Na Guo, et al.. (2011). Preparation of oligosaccharides by homogenous enzymatic synthesis and solid phase extraction. Chemical Communications. 47(40). 11240–11240. 6 indexed citations

20.

Wang, Wenjun, Howard Edington, Uma N. M. Rao, et al.. (2008). STAT3 as a Biomarker of Progression in Atypical Nevi of Patients with Melanoma: Dose–Response Effects of Systemic IFNα Therapy. Journal of Investigative Dermatology. 128(8). 1997–2002. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact